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j ourna l homepage: www.e lsev ie r .com/ locate /goreLetter to the EditorLetter to Editor in response to “Detection of
endometrial cancer via molecular analysis of DNA
collected with vaginal tampons” by
Bakkum-Gamez et al. (Gynecol Oncol. 2015)We read with great interest the article by Bakkum-Gamez et al.
“Detection of endometrial cancer via molecular analysis of DNA collected
with vaginal tampons” in the recent edition of Gynecologic Oncology
(Bakkum-Gamez et al., 2015).
According to Authors, we believe that endometrial cancer (EC) will
become an even more important public health issue in next years. In
developed countries, the incidence of EC has raised only slightly over
the past two decades although the number of annual estimated deaths
from this disease has more than doubled since the 1980s. Recent ﬁnd-
ings suggest that the increase in mortality over the last 14 years may
be related to an increased rate of advanced-stage cancers, higher
tumor grade and non-endometrioid histology (Ueda et al., 2008). For
these reasons scientists, doctors, and public health professionals are
more concerned than ever before with identifying effective preventive
measures for this condition, which has a readily available treatment
with a potential for cure that increases with early detection. Along
with primary prevention through modiﬁcation of lifestyle and risk
factors, we believe that next generation strategies should include
periodical screening in high-risk subjects.
Interestingly Bakkum-Gamez et al. demonstrate the feasibility of
detecting EC by combining minimally-invasive specimen collection
techniques with sensitive molecular testing (Bakkum-Gamez et al.,
2015). Intravaginal tampons and Tao brush were used respectively to
collect vaginal pool and liquid-based endometrial cytology (LBEC)
prior to hysterectomy for EC or benign conditions. Tampon and brush
DNA underwent separately pyrosequencing assays showing a higher
gene-level methylation of both well-studied and recently identiﬁed
markers for EC. Although the higher methylation among the EC group
compared to BE group, a subset of EC methylation overlaps with the
distribution of BE methylation. Additional discovery efforts to identify
other novel candidate biomarkers to improve test sensitivity and pre-
dictive value are warranted.
HOXA9, previously reported as methylated in normal endometrium
of women presenting with ovarian cancer (Widschwendter et al.,
2009), was included in the panel of genes demonstrating a methylation
pattern comparable with RASSF1, a gene methylated in nearly 90% of
ECs.
Homeobox (HOX) genes encode transcriptional factors involved in
embryonic development. During development of the female reproductive
systemHOXA9, HOXA10, HOXA11, andHOXA13 are expressed uniformly
along the Müllerian duct axis, although in adults their expression
becomes spatially restricted to particular organs. HOXA9 becomes
expressed in the fallopian tubes; HOXA10 is expressed in the developing
uterus, HOXA11 in the lower uterine segment and cervix and HOXA13 in
the upper vagina (Taylor et al., 1997).http://dx.doi.org/10.1016/j.gore.2015.04.003
2352-5789/© 2015 The Authors. Published by Elsevier Inc. This is an open access article underSeveral studies havedemonstrated thatHOXA10 is cyclically expressed
in endometrial glands and stroma throughout the menstrual cycle and
that aberrant expression of HOXA 10 by the epigenetic mechanism
of methylation is associated with infertility and endometriosis
(Taylor et al., 1998; Andersson et al., 2014; Fambrini et al., 2013a).
Recently, our group has reported themethylation proﬁle of HOXA10
promoter gene in EC and normal endometrial tissues obtained in differ-
ent phases of menstrual cycle (Fambrini et al., 2013b). There were
statistically signiﬁcant differences in mean methylation between EC
and normal endometrium, suggesting a possible role of epigenetic
changes in HOXA10 gene regulation in EC. This data are in agreement
with other studies (Yoshida et al., 2006) indicating that HOXA 10 is
aberrantly expressed in EC, and that its deregulation signiﬁcantly con-
tributes to tumor progression. Therefore, we believe that HOXA10
should be included in the panel of genes selected by the Authors to
improve test performance.
Concerning DNA collection method, vaginal tampon can potentially
enable self-collection and delivery to a testing laboratory by mail,
extending access to EC early detectionmethods into settingwith limited
resources. However the impact of previous biopsy on tumor cell and
cell-free DNA shedding in unknown and the interpretation of study is
limited by collection of samples following prior endometrial instrumen-
tation. Specimens of the study included also endometrial brushing
collected via Tao brush and suspended in liquid-based solution. The
median amount of DNA collected from endometrial brushing was
higher respect to vaginal pool via tampon, even if both collection
techniques yielded sufﬁcient DNA quantities for methylation analysis
and methylation levels between EC and BE were similar. However, an
utmost relevant point is that LBEC provides the opportunity to obtain
amorphological diagnosis according to accurate and standardized diag-
nostic criteria. Since 2003, the use of LBEC has been described by several
authors in different study populations. Overall, cumulative literature on
nearly four thousand patients revealed sensitivity of 78–100%, a speci-
ﬁcity of 95–1000%, a positive predictive value (PPV) of 78–100%, and a
negative predictive value (NPV) of 96–100% (Buccoliero et al., 2007,
2008; Fambrini et al., 2008, 2012, 2014; Kipp et al., 2008).
We reported a very high diagnostic accuracy of LBEC in early detec-
tion of EC, even in troublesome subgroups of women such as tamoxifen
users (Buccoliero et al., 2008), post-menopausal subjects (Buccoliero
et al., 2007) or patients with low-risk endometrial polyps (Fambrini
et al., 2008). In speculating on the role of LBEC as ﬁrst line investigation,
we combined LBEC and transvaginal ultrasounds in women with post-
menopausal bleeding observing a 100% sensitivity with 100% NPV in
EC identiﬁcation (Fambrini et al., 2012).
LBECmeetsmost of the ideal screening test requirements such as the
low rate of inadequate specimens, the reasonable cost (comparable to a
liquid-based pap test), the good acceptability and the ease of execution
in an ofﬁce setting.
We thank Bakkum-Gamez et al. for giving the attention to early de-
tection of EC, supporting a screening policy in high-risk population. Fur-
ther studies evaluating cost-effectiveness are needed to assess the best
screening modalities in developed countries. However, we believe thatthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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analysis, could be used as an outpatient testing for early detection of
EC in groups of women with a higher overall incidence of disease.
Conﬂicts of interest
The authors declare that there are no conﬂicts of interest.
References
Andersson, K.L., Bussani, C., Fambrini, M., Polverino, V., Taddei, G.L., Gemzell-Danielsson,
K., et al., 2014. DNA methylation of HOXA10 in eutopic and ectopic endometrium.
Hum. Reprod. 29 (9), 1906–1911.
Bakkum-Gamez, J.N., Wentzensen, N., Maurer, M.J., Hawthorne, K.M., Voss, J.S., Kroneman,
T.N., et al., 2015. Detection of endometrial cancer via molecular analysis of DNA col-
lected with vaginal tampons. Gynecol. Oncol. 137 (1), 14–22 (Feb 10. pii: S0090-
8258(15)00604-6).
Buccoliero, A.M., Gheri, C.F., Castiglione, F., Garbini, F., Barbetti, A., Fambrini, M., et al.,
2007. Liquid-based endometrial cytology: cyto-histological correlation in a popula-
tion of 917 women. Cytopathology 18 (4), 241–249.
Buccoliero, A.M., Fambrini, M., Gheri, C.F., Castiglione, F., Garbini, F., Barbetti, A., et al.,
2008. Surveillance for endometrial cancer in women on tamoxifen: the role of
liquid-based endometrial cytology—cytohistological correlation in a population of
168 women. Gynecol. Obstet. Investig. 65 (4), 240–246.
Fambrini, M., Buccoliero, A.M., Bargelli, G., Cioni, R., Piciocchi, L., Pieralli, A., et al., 2008.
Clinical utility of liquid-based cytology for the characterization and management of
endometrial polyps in postmenopausal age. Int. J. Gynecol. Cancer 18 (2), 306–311.
Fambrini, M., Buccoliero, A.M., Pieralli, A., Taddei, G.L., 2012. A pilot study evaluating
liquid-based endometrial cytology and transvaginal ultrasonography in women
with postmenopausal bleeding. Cytopathology. http://dx.doi.org/10.1111/cyt.12027.
Fambrini, M., Sorbi, F., Bussani, C., Cioni, R., Sisti, G., Andersson, K.L., 2013a. Hyper-
methylation of HOXA10 gene in mid-luteal endometrium from women with
ovarian endometriomas. Acta Obstet. Gynecol. Scand. 92, 1331–1334.
Fambrini, M., Bussani, C., Sorbi, F., Pieralli, A., Cioni, R., 2013b. Methylation of the HOXA10
homeobox gene promoter is associated with endometrial cancer: a pilot study.
J. Obstet. Gynaecol. 33 (5), 519–520.
Fambrini, M., Sorbi, F., Sisti, G., Cioni, R., Turrini, I., Taddei, G., et al., 2014. Endometrial
carcinoma in high-risk populations: is it time to consider a screening policy?
Cytopathology 25 (2), 71–77.Kipp, B.R., Medeiros, F., Campion, M.B., Distad, T.J., Peterson, L.M., Keeney, G.L., et al., 2008.
Direct uterine sampling with the Tao brush sampler using a liquid-based preparation
method for the detection of endometrial cancer and atypical hyperplasia: a feasibility
study. Cancer 114 (4), 228–235.
Taylor, H.S., Vanden Heuvel, G.B., Igarashi, P., 1997. A conserved Hox axis in the mouse
and human female reproductive system: late establishment and persistent adult
expression of the Hoxa cluster genes. Biol. Reprod. 57 (6), 1338–1345.
Taylor, H.S., Arici, A., Olive, D., Igarashi, P., 1998. HOXA10 is expressed in response to sex
steroids at the time of implantation in the human endometrium. J. Clin. Invest. 101
(7), 1379–1384.
Ueda, S.M., Kapp, D.S., Cheung, M.K., Shin, J.Y., Osann, K., Husain, A., et al., 2008. Trends in
demographic and clinical characteristics inwomen diagnosedwith corpus cancer and
their potential impact on the increasing number of deaths. Am. J. Obstet. Gynecol. 198
(2) (218.e1-6).
Widschwendter, M., Apostolidou, S., Jones, A.A., Fourkala, E.O., Arora, R., Pearce, C.L., et al.,
2009. HOXA methylation in normal endometrium from premenopausal women is
associated with the presence of ovarian cancer: a proof of principle study. Int.
J. Cancer 125 (9), 2214–2218.
Yoshida, H., Broaddus, R., Cheng, W., Xie, S., Naora, H., 2006. Deregulation of the HOXA10
homeobox gene in endometrial carcinoma: role in epithelial–mesenchymal transition.
Cancer Res. 66 (2), 889–897.
Massimiliano Fambrini*
Cecilia Bussani
Flavia Sorbi
Department of Biomedical, Clinical and Experimental Sciences,
University of Florence, Florence, Italy
*Corresponding author at: Department of Biomedical, Clinical and
Experimental Sciences, University of Florence, Viale Morgagni, 85,
50134 Florence, Italy. Fax: +39 055 430056.
E-mail address:maxfambrini@libero.it (M. Fambrini).
31 March 2015
